IMMUNE-FRAME Trademark

Trademark Overview

On Wednesday, March 30, 2022, a trademark application was filed for IMMUNE-FRAME with the United States Patent and Trademark Office. The USPTO has given the IMMUNE-FRAME trademark a serial number of 79344807. The federal status of this trademark filing is REGISTERED as of Tuesday, December 19, 2023. This trademark is owned by R.G.C.C. Holdings AG. The IMMUNE-FRAME trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

medical diagnosis services, namely medical analysis services for the diagnosis of all types of cancer
immune-frame

General Information

Serial Number79344807
Word MarkIMMUNE-FRAME
Filing DateWednesday, March 30, 2022
Status700 - REGISTERED
Status DateTuesday, December 19, 2023
Registration Number7245007
Registration DateTuesday, December 19, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 3, 2023

Trademark Statements

Goods and Servicesmedical diagnosis services, namely medical analysis services for the diagnosis of all types of cancer

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 15, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameR.G.C.C. Holdings AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameR.G.C.C. Holdings AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameR.G.C.C. Holdings AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Tuesday, April 2, 2024FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, April 2, 2024FINAL DISPOSITION PROCESSED
Tuesday, March 19, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 19, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 19, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, October 4, 2023NOTIFICATION PROCESSED BY IB
Tuesday, October 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2023PUBLISHED FOR OPPOSITION
Wednesday, September 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 13, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 13, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 28, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 28, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 28, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 5, 2023REFUSAL PROCESSED BY IB
Tuesday, March 14, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 14, 2023REFUSAL PROCESSED BY MPU
Friday, January 20, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, January 19, 2023NON-FINAL ACTION WRITTEN
Friday, January 13, 2023ASSIGNED TO EXAMINER
Tuesday, July 19, 2022APPLICATION FILING RECEIPT MAILED
Friday, July 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 14, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

frame immune medical services diagnosis cancer types namely analysis